Excessive Daytime Sleepiness Clinical Trials in New York, New York
2 recruitingNew York, New York
Showing 1–2 of 2 trials
Recruiting
Phase 3
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Axsome Therapeutics, Inc.508 enrolled40 locationsNCT07484217
Recruiting
Phase 1
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
Excessive Daytime Sleepiness
Centessa Pharmaceuticals (UK) Limited208 enrolled3 locationsNCT07082829